NCT00825396View on ClinicalTrials.gov

An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions

Ocular Hypertension

Interventions

DRUG

C-KAD Ophthalmic Solution

4 drops applied daily for 150 days

Trial Locations (1)

28210

Charlotte Eye, Ear, Nose & Throat Associates, Charlotte

All Listed Sponsors

lead

Chakshu Research, Inc.

INDUSTRY

NCT00825396 - An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension | Biotech Hunter | Biotech Hunter